UK markets closed

Oncopeptides AB (publ) (0RN4.IL)

IOB - IOB Delayed price. Currency in SEK
Add to watchlist
3.0000+0.0650 (+2.21%)
At close: 06:00PM BST
Full screen
Previous close2.9350
Open2.9548
Bid2.8500 x N/A
Ask3.1500 x N/A
Day's range2.9548 - 3.0305
52-week range2.8900 - 11.2450
Volume18,527
Avg. volume8,938
Market cap307.671M
Beta (5Y monthly)-0.66
PE ratio (TTM)N/A
EPS (TTM)-3.3900
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

    DUBAI, United Arab Emirates and STOCKHOLM, Sweden, March 27, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO (“Vector”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in the Middle East and North Africa (“MENA”) countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq. Under the terms of this e